DARA BioSciences, Inc.·4

Jan 3, 6:13 PM ET

FRANCO RICHARD A 4

4 · DARA BioSciences, Inc. · Filed Jan 3, 2011

Insider Transaction Report

Form 4
Period: 2010-12-30
FRANCO RICHARD A
DirectorPresident & CEO
Transactions
  • Purchase

    Series A Convertible Preferred Stock

    2010-12-30$1000.00/sh+200$200,00080,000 total
    Exercise: $2.50Common Stock (80,000 underlying)
Holdings
  • Common Stock

    112,835
Footnotes (1)
  • [F1]Series A convertible preferred stock is convertible into common stock at any time at a rate of 400-for-1 and has no expiration date.

Documents

1 file
  • 4
    rrd295943.xmlPrimary

    FRANCO PREFERRED STOCK PURCHASE (DEC. 2010)